• Health Care M&A Deals, September 18, 2020

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal... Read More »
  • MetLife Acquires Versant Health

    MetLife, Inc. (NYSE: MET) has entered the healthcare M&A market. Last week, the company announced the acquisition of Versant Health, the parent company of Davis Vision and Superior Vision, two major vision care and insurance brands with a combined 35 million members. Centerbridge Partners and an investor group including FFL Partners are... Read More »
  • CloudMD Expands Patient Engagement Portfolio

    CloudMD Software & Services Inc. (OTCMKTS: DOCRF) just keeps rolling out new deals and acquisitions. The company has been very active this year, with six acquisitions on the books so far across various sectors, according to search results in our Deal Search Online database. Last week, CloudMD acquired Toronto-based iMD Health Global Corp. for... Read More »
  • Trulieve Cannabis Boosts Its Market Reach

    Trulieve Cannabis Corp. (OTC: TCNNF), a vertically integrated “seed-to-sale” company and the first licensed medical cannabis company in the state of Florida, announced two new transactions last week. M&A activity in the medical marijuana market has been quiet throughout 2020 and 2019, after experiencing somewhat of a boom in 2018,... Read More »
  • A Busy Week for Home Health & Hospice Deals

    It was a busy week for home health & hospice (HH&H) transactions. Results from our Deal Search Online database show there were four announced last week alone, half of September’s total so far. Half of the deals were completed by private equity-backed companies, which highlights the continued interest in HH&H from PE firms. Jet... Read More »

Fresenius Banks on Dialysis at Home

Fresenius, a global leader in dialysis, brings dialysis into the home with a $2 billion deal. As hospitals and other providers face mounting pressure to deliver high-quality, lower cost services, one company has taken the initiative to become a world-leader in at-home critical care. On August 7, 2017, Fresenius Medical Care (NYSE: FMS) acquired NxStage Medical, Inc. (NASDAQ: NXTM) for $2.0 billion. Fresenius Medical Care will acquire all outstanding shares of NxStage for $30.00 per common share, valuing the deal at approximately $2.0 billion, including $1.24 million of debt. Multiples work out to 5.11x revenue and 7.97x EBITDA. Based in Boston, NxStage Medical develops, manufactures, and... Read More »